-
1
Histone acetylation modulators in breast cancer
Published 2025-03-01“…Breast Cancer Research…”
Get full text
Article -
2
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
3
Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural e...
Published 2025-05-01“…Breast Cancer Research…”
Get full text
Article -
4
A hybrid epithelial-mesenchymal transition program enables basal epithelial cells to bypass stress-induced stasis and contributes to a metaplastic breast cancer progenitor state
Published 2024-12-01“…Breast Cancer Research…”
Get full text
Article -
5
Neoadjuvant chemotherapy response in androgen receptor-positive triple-negative breast cancer: potential predictive biomarkers and genetic alterations
Published 2025-03-01“…Breast Cancer Research…”
Get full text
Article -
6
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
Published 2025-02-01“…Breast Cancer Research…”
Get full text
Article -
7
Associations of perfluoroalkyl substances (PFAS) with terminal ductal lobular unit involution of the normal breast
Published 2025-08-01“…Breast Cancer Research…”
Get full text
Article -
8
Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
9
Neutrophil extracellular traps induced by neoadjuvant chemotherapy of breast cancer promotes vascular endothelial damage
Published 2025-04-01“…Breast Cancer Research…”
Get full text
Article -
10
CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation
Published 2025-05-01“…Breast Cancer Research…”
Get full text
Article -
11
Correction: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
12
Quantifying tumor morphological complexity based on pretreatment MRI fractal analysis for predicting pathologic complete response and survival in breast cancer: a retrospective, mu...
Published 2025-05-01“…Breast Cancer Research…”
Get full text
Article -
13
Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma
Published 2025-07-01“…Breast Cancer Research…”
Get full text
Article -
14
Hsp47 drives obesity-associated breast cancer progression by enhancing asporin deposition in adipose tissue
Published 2025-07-01“…Breast Cancer Research…”
Get full text
Article -
15
Longitudinal history of mammographic breast density and breast cancer risk by familial risk, menopausal status, and initial mammographic density level in a high risk cohort: a nest...
Published 2024-11-01“…Breast Cancer Research…”
Get full text
Article -
16
Missense variants in PRKCD: elucidating their potential association with breast cancer
Published 2025-07-01“…Breast Cancer Research…”
Get full text
Article -
17
Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis
Published 2024-11-01“…Breast Cancer Research…”
Get full text
Article -
18
Medications to reduce breast cancer risk: a network meta-analysis of randomized controlled trials
Published 2025-07-01“…Breast Cancer Research…”
Get full text
Article -
19
Genomic alterations in normal breast tissues preceding breast cancer diagnosis
Published 2025-04-01“…Breast Cancer Research…”
Get full text
Article -
20
Optimizing breast lesions diagnosis and decision-making with a deep learning fusion model integrating ultrasound and mammography: a dual-center retrospective study
Published 2025-05-01“…Breast Cancer Research…”
Get full text
Article